Good chance to top up after the Novartis announcement. We all know strings would be pulled after the worlds largest bio pharmaceutical company is partnered with Mesoblast. This is the first step, next will be GVHD as the randomized controlled study is already started.
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-140
-
- There are more pages in this discussion • 433 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.41 |
Change
-0.035(2.43%) |
Mkt cap ! $1.627B | |||
| Open | High | Low | Value | Volume |
| $1.44 | $1.46 | $1.40 | $1.552M | 1.091M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 14478 | $1.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.41 | 13833 | 9 |
View Market Depth
| Last trade - 13.06pm 15/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |